In development: Indicators
Showing 1 to 7 of 7
| Title | Type | Expected publication date |
|---|---|---|
| Diabetes: T1DM and lipid lowering therapies | TBC | |
| Diabetes: lipid lowering therapies for secondary prevention of CVD | TBC | |
| Diabetes: lipid lowering therapies for primary prevention of CVD (40 years and over) | TBC | |
| Diabetes: lipid lowering therapies for primary prevention of CVD (T2DM and 10% risk) | TBC | |
| Asthma: annual review | TBC | |
| Asthma: objective tests | TBC | |
| Atrial fibrillation: pulse rhythm assessment in people at risk | General practice indicators suitable for use outside of QOF | TBC |